Search Results 601-610 of 17658 for protein intake optimization

  1. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Antibody-drug conjugates, such as lorvotuzumab mertansine, are created by attaching an antibody (protein ...

  2. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...

  3. Neurosurgery - Clinical trials

    Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic SPORE, “Optimal ...

  4. Neurosurgery - Clinical trials

    ... protein CMVpp65. Cohort 1 includes blood ... Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. ... Students · Admissions ...

  5. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have discovered a new role that a specific protein plays in regulating cell resistance and fighting tumors in certain types of cancer.

  6. An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Serum M-protein ≥1 g/dL (≥10 g/L); OR; Urine M ... Patient is willing and able to adhere to the study visit ...

  7. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... requirements. Exclusion Criteria: Subjects who have ... protein (IDH). Participating Mayo Clinic ...

  8. Advancing patient care through glaucoma research - Mayo Clinic

    "The collective goal is to connect patients with optimal treatment options and improve overall outcomes. ... protein and produces IOP reduction for up to six ...

  9. Neurology - Clinical trials - Mayo Clinic

    Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic SPORE, “Optimal ...

  10. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Blood Tube Optimization Program hails first successful project featured image. Research. Science Saturday: Blood Tube Optimization ...